Related Experiment Video
Updated: Feb 21, 2026
Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
Published on: July 11, 2025
Hypoxia-induced hypomyelination in the developing brain is mammalian target of rapamycin-4E-binding protein-1
Faton Bilali1, Pranav Kumar, John Feerick
1Department of Cell Biology and Anatomy, New York Medical College, Valhalla, New York 10595, USA.
Abstract:
We hypothesized that changes in the expression levels of genes in the mammalian target of rapamycin are involved in the hypoxia-induced growth retardation in the brain including hypomyelination. Microarray and proteomic studies showed a 2.3-fold increase in the expression levels of eukaryotic translation initiation factor 4E-binding protein-1 and a 3-fold decrease in the levels of FK506-binding protein-1 in a neonatal model of hypoxia, indicating a signal transduction impairment through mammalian target of rapamycin (mTOR). Analysis of hypoxic brain showed a marked decrease in the phosphorylation levels of 4E-binding protein-1, suggesting a reduction of mTOR activity. These data suggest that suppression of mTOR may be the mechanism underlying hypoxia-induced hypomyelination observed in the developing brain.
Insights
Hypoxia impairs brain development and myelination by suppressing the mammalian target of rapamycin (mTOR) pathway. This study identifies key protein changes indicating reduced mTOR activity, linking it to hypomyelination in neonatal hypoxia.
Area of Science:
- Neuroscience
- Molecular Biology
- Developmental Biology
Background:
- Hypoxia can cause brain growth retardation and hypomyelination in newborns.
- The mammalian target of rapamycin (mTOR) pathway regulates cell growth and protein synthesis.
- Dysregulation of mTOR signaling is implicated in various neurological disorders.
Purpose of the Study:
- To investigate the role of the mammalian target of rapamycin (mTOR) pathway in hypoxia-induced brain growth retardation and hypomyelination.
- To identify specific molecular changes associated with mTOR signaling impairment under hypoxic conditions.
Main Methods:
- Utilized a neonatal model of hypoxia.
- Performed microarray and proteomic analyses to assess gene and protein expression.
- Analyzed protein phosphorylation levels to determine mTOR pathway activity.
Main Results:
- Observed a 2.3-fold increase in eukaryotic translation initiation factor 4E-binding protein-1 (4E-BP1) expression.
- Detected a 3-fold decrease in FK506-binding protein-1 levels.
- Found a significant reduction in the phosphorylation of 4E-BP1 in hypoxic brain tissue, indicating decreased mTOR activity.
Conclusions:
- Suppression of the mTOR pathway is a key mechanism underlying hypoxia-induced hypomyelination in the developing brain.
- Changes in 4E-BP1 and FK506-binding protein-1 expression are indicators of mTOR pathway impairment during neonatal hypoxia.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
10:00Production and Use of Lentivirus to Selectively Transduce Primary Oligodendrocyte Precursor Cells for In Vitro Myelination Assays
Published on: January 12, 2015
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
01:24Regulation of Angiogenesis and Blood Supply
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...